SEC Tracker
Get the app

Jaguar Health JAGX

Jaguar Health amends stock plan

Additional proxy materials

Form
DEFA14A
Filed
Importance
Routine
  1. Proposal 3 seeks 14% of shares for 2014 Plan
  2. Share reserve increased 6x to 2,273,154 shares
  3. Series R Preferred Stock Dividend paid on Oct 15, 2026
  4. Conversion ratio of 5 shares of Common Stock per Series R Preferred Share

Written from the DEFA14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Jaguar Health files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Theriva Biologics TOVX public float $4M, Jun 30, 2025
  2. Q/C Technologies QCLS public float $4M, Jun 30, 2025
  3. Polomar Health Services PMHS public float $4M, Jun 30, 2025
  4. Enveric Biosciences ENVB public float $4M, Jun 30, 2025
  5. Healthy Extracts HYEX public float $4M, Jun 30, 2025